Chemokines in tumor progression and metastasis

Purvaba J. Sarvaiya; Donna Guo; Ilya V. Ulasov; Patrik Gabikian; Maciej S. Lesniak

doi:10.18632/oncotarget.1426

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Chemokines in tumor progression and metastasis

Purvaba J. Sarvaiya _, Donna Guo, Ilya V. Ulasov, Patrik Gabikian and Maciej S. Lesniak

PDF | HTML | How to cite

Oncotarget. 2013; 4:2171-2185. https://doi.org/10.18632/oncotarget.1426

Metrics: PDF 5584 views | HTML 7735 views | ?

Abstract

Purvaba J. Sarvaiya1, Donna Guo1, Ilya Ulasov1, Patrik Gabikian1 and Maciej S. Lesniak1

1 The Brain Tumor Center, The University of Chicago, Chicago, Illinois, USA

Correspondence:

Maciej S. Lesniak, email:

Keywords: Chemokines, chemokine receptors, cancer, metastasis

Received: September 19, 2013 Accepted: November 8, 2013 Published: November 9, 2013

Abstract

Chemokines play a vital role in tumor progression and metastasis. Chemokines are involved in the growth of many cancers including breast cancer, ovarian cancer, pancreatic cancer, melanoma, lung cancer, gastric cancer, acute lymphoblastic leukemia, colon cancer, non-small lung cancer and non-hodgkin’s lymphoma among many others. The expression of chemokines and their receptors is altered in many malignancies and leads to aberrant chemokine receptor signaling. This review focuses on the role of chemokines in key processes that facilitate tumor progression including proliferation, senescence, angiogenesis, epithelial mesenchymal transition, immune evasion and metastasis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 1426

Publication Alerts

Reviews:

Chemokines in tumor progression and metastasis

Abstract